On December 25th, 2020, Authority Magazine interviewed Co-Founder and CEO, Dr. Selin Kurnaz of Massive Bio, Artificial Intelligence (AI) Clinical Trial Enrollment Startup. She spoke about her upbringing and adulthood filled with perseverance despite obstacles along the way, noting that “Unfortunately, there is no short-cut for success, you need to work super hard, be ready for massive set-backs, never give up on your values, never give up learning and never giving up standing up when you fall down. In the end, success is a marathon with daily sprints”. Selin contributes Massive Bio’s rapid growth and enormous wins to self-discipline, good habits, and a supportive network.
When questioned what or who inspired Selin to pursue her career in Oncology, Selin mentioned that when her uncle became diagnosed with cancer, her family was deeply affected. Despite her busy days climbing the corporate ladder at world-renowned NYC banks and consulting firms, Selin aspired to change the future of oncology to enable clinical trial access for her family and for the world, thus beginning Massive Bio.
Most notable remarks during the interview, which capture Selin’s riveting projects direction with the company, include further building the company’s mission to use their AI-driven platform to connect cancer patients regardless of his/her location and/or financial stability to clinical trials. As a near-future goal, Selin wishes to use her influence to inspire a movement to bring up clinical trial enrollment rates up to 20% in the United States.
Read Dr. Selin Kurnaz’s full interview here.